News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
526,593 Results
Type
Article (52193)
Company Profile (142)
Press Release (474258)
Section
Business (145060)
Career Advice (2228)
Deals (22678)
Drug Delivery (63)
Drug Development (66878)
Employer Resources (115)
FDA (11781)
Job Trends (11104)
News (248321)
Policy (21081)
Tag
Academia (2755)
Alliances (39758)
Alzheimer's disease (1283)
Approvals (11809)
Artificial intelligence (189)
Bankruptcy (162)
Best Places to Work (9003)
Breast cancer (201)
Cancer (1611)
Career advice (1816)
CAR-T (117)
Cell therapy (342)
Clinical research (53202)
Collaboration (646)
Compensation (207)
COVID-19 (2169)
C-suite (149)
Data (1595)
Diabetes (183)
Diagnostics (5011)
Earnings (51035)
Events (75215)
Executive appointments (525)
FDA (12611)
Funding (551)
Gene therapy (215)
GLP-1 (493)
Government (3179)
Healthcare (14518)
Infectious disease (2262)
Inflammatory bowel disease (106)
Interviews (415)
IPO (10868)
Job creations (2507)
Job search strategy (1590)
Layoffs (315)
Legal (3887)
Lung cancer (231)
Lymphoma (107)
Manufacturing (188)
Medical device (9024)
Medtech (9026)
Mergers & acquisitions (12218)
Metabolic disorders (425)
Neuroscience (1651)
NextGen: Class of 2025 (4644)
Non-profit (4036)
Northern California (1807)
Obesity (201)
Opinion (190)
Parkinson's disease (111)
Patents (131)
People (45739)
Phase I (16805)
Phase II (23291)
Phase III (17513)
Pipeline (696)
Postmarket research (2180)
Preclinical (8005)
Radiopharmaceuticals (212)
Rare diseases (251)
Real estate (4519)
Regulatory (15423)
Research institute (2557)
Resumes & cover letters (357)
Southern California (1547)
Startups (2803)
United States (15649)
Vaccines (516)
Weight loss (123)
Date
Today (108)
Last 7 days (655)
Last 30 days (2303)
Last 365 days (28506)
2025 (4561)
2024 (28736)
2023 (32455)
2022 (43035)
2021 (46023)
2020 (42948)
2019 (35849)
2018 (27072)
2017 (25619)
2016 (24906)
2015 (29472)
2014 (22470)
2013 (19505)
2012 (19773)
2011 (20739)
2010 (18836)
Location
Africa (737)
Asia (32611)
Australia (5843)
California (4095)
Canada (1413)
China (360)
Colorado (170)
Connecticut (217)
Delaware (107)
Europe (75609)
Florida (598)
Georgia (136)
Illinois (377)
Indiana (203)
Japan (121)
Maryland (648)
Massachusetts (3068)
Michigan (161)
Minnesota (223)
New Jersey (1226)
New York (1238)
North Carolina (712)
Northern California (1807)
Ohio (153)
Pennsylvania (847)
South America (886)
Southern California (1547)
Texas (579)
Utah (111)
Washington State (438)
526,593 Results for "d e shaw research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
Cellares, a leader in the automation of cell therapy manufacturing and the world’s first Integrated Development and Manufacturing Organization, announced the addition of Christi Shaw to its Advisory Board.
March 26, 2024
·
4 min read
Job Trends
D. E. Shaw Research Licenses First-in-Class Therapeutic for Immunological Diseases to Lilly
D. E. Shaw Research (DESRES) today announced that it has entered into an exclusive global license agreement with Eli Lilly and Company (Lilly) for the clinical development and commercialization of DESRES’s program of Kv1.3-targeted therapeutics for the treatment of various immunological and inflammatory diseases.
June 13, 2022
·
2 min read
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
Business
Evecxia Therapeutics Strengthens Board of Directors With Appointments of Allan L. Shaw and Elliot Ehrich
Evecxia Therapeutics, Inc. today announced the appointments of Allan L. Shaw and Elliot Ehrich, MD to its Board of Directors, bringing with them decades of leadership experience in the biopharmaceutical industry.
October 30, 2023
·
4 min read
Press Releases
Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic
February 10, 2025
·
4 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
Terremoto Biosciences Appoints James Christensen, Ph.D., as President and Head of Research & Development
January 10, 2025
·
3 min read
Press Releases
Aardvark Therapeutics Appoints Renowned Biopharma Leaders Roy D. Baynes and Susan E. Graf to its Board of Directors
January 9, 2025
·
5 min read
Press Releases
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
November 11, 2024
·
6 min read
Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research
January 27, 2025
·
3 min read
1 of 52,660
Next
